Cees G. M. Kallenberg

38.5k citations

369 papers · 18.0k indexed · 2 hit papers · h-index 72

Pulmonary and Respiratory Medicine top 0.1%
Immunology top 0.1%
Rheumatology top 0.05%
Physiology top 0.5%
Molecular Biology top 2%

Co-authors: Coen A. Stegeman Jan Willem Cohen Tervaert Pieter C. Limburg Marc Bijl Peter Heeringa Wayel H. Abdulahad P. C. Limburg Gerda Horst
Topics: Vasculitis and related conditions (184 papers)Systemic Lupus Erythematosus Research (83 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (60 papers)
Cited by: Rheumatology Immunology Nephrology
Journals: New England Journal of Medicine The Lancet Journal of Clinical Investigation
Partner nations: Netherlands United States Pakistan

In The Last Decade

Cees G. M. Kallenberg

368 papers receiving 17.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis

1996 538 citations Coen A. Stegeman, Jan Willem Cohen Tervaert et al. profile →
EULAR recommendations for the management of large vessel vasculitis

2008 431 citations Cees G. M. Kallenberg, Peter A. Merkel et al. profile →

Peers

Countries citing papers authored by Cees G. M. Kallenberg

Since Specialization

Citations

This map shows the geographic impact of Cees G. M. Kallenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cees G. M. Kallenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cees G. M. Kallenberg more than expected).

Fields of papers citing papers by Cees G. M. Kallenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cees G. M. Kallenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cees G. M. Kallenberg. The network helps show where Cees G. M. Kallenberg may publish in the future.

Co-authorship network of co-authors of Cees G. M. Kallenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Cees G. M. Kallenberg. A scholar is included among the top collaborators of Cees G. M. Kallenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cees G. M. Kallenberg. Cees G. M. Kallenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3 2022 ·Arthritis & Rheumatology ·Marta Casal Moura,(unknown),Darlene R. Nelson,Lynn A. Fussner,Amber M. Hummel,Dieter E. Jenne,Daniel Emerling,Fernando C. Fervenza,Cees G. M. Kallenberg,Carol A. Langford,W. Joseph McCune,Peter A. Merkel,Paul A. Monach,Philip Seo,Robert Spiera,E. William St. Clair,Steven R. Ytterberg,John H. Stone,William H. Robinson,Ulrich Specks	1
2	Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis 2020 ·JCI Insight ·Kasia Owczarczyk,Matthew D. Cascino,Cécile Holweg,Gaik W. Tew,Ward Ortmann,Timothy W. Behrens,Thomas H. Schindler,Carol A. Langford,E. William St. Clair,Peter A. Merkel,Robert Spiera,Philip Seo,Cees G. M. Kallenberg,Ulrich Specks,Noha Lim,John H. Stone,Paul Brunetta,Marco Prunotto	9
3	Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need? 2018 ·PubMed ·Sophie Mavrogeni,George D. Kitas,Hildo J. Lamb,(unknown),Theodoros Dimitroulas,Λουκία Κουτσογεωργοπούλου,Kyriaki Boki,(unknown),Genovefa Kolovou,George Markousis‐Mavrogenis,Cees G. M. Kallenberg,(unknown),Dimitrios Vassilopoulos	5
4	Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis 2018 ·Arthritis & Rheumatology ·Alvise Berti,Roscoe L. Warner,Kent J. Johnson,Divi Cornec,Darrell R. Schroeder,Brian Kabat,Carol A. Langford,Gary S. Hoffman,(unknown),Cees G. M. Kallenberg,Philip Seo,Robert Spiera,E. William St. Clair,Paul Brunetta,John H. Stone,(unknown),Ulrich Specks,Paul A. Monach	48
5	Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides 2017 ·Scientific Reports ·Corinna Glasner,Marcus C. de Goffau,Mirjan M. van Timmeren,Mirja L. Schulze,(unknown),Mehri Tavakol,Willem J. B. van Wamel,Coen A. Stegeman,Cees G. M. Kallenberg,Jan P. Arends,John W. A. Rossen,Peter Heeringa,Jan Maarten van Dijl	21
6	HMGB1 Is An Important Mediator in Cutaneous Inflammation in Systemic Lupus Erythematosus (SLE) 2011 ·Data Archiving and Networked Services (DANS) ·(unknown),Johanna Westra,Gerda Horst,Pieter C. Limburg,Cees G. M. Kallenberg,Marc Bijl	1
7	The Relation Between Daily Physical Activity Measured with the Accelerometer and Clinical Assessments in Patients with Ankylosing Spondylitis 2011 ·Data Archiving and Networked Services (DANS) ·Suzanne Arends,Y.P.T. Kamsma,E. van der Veer,M. K. Leijsma,P. M. Houtman,Cees G. M. Kallenberg,Anneke Spoorenberg,Elisabeth Brouwer,(unknown)	2
8	Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study 2011 ·The Journal of Rheumatology ·Rodney Pollard,Justin Pijpe,Hendrika Bootsma,Fred K. L. Spijkervet,Philip M. Kluin,Jan L.N. Roodenburg,Cees G. M. Kallenberg,Arjan Vissink,Gustaaf W. van Imhoff	51
9	Refractory vasculitis 2011 ·Autoimmunity Reviews ·Abraham Rutgers,Cees G. M. Kallenberg	13
10	Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor 2010 ·BMC Musculoskeletal Disorders ·Johanna Westra,Elisabeth Brouwer,(unknown),Berber Doornbos‐van der Meer,M. A. van Leeuwen,Marcel D. Posthumus,Cees G. M. Kallenberg	51
11	Role for CaMKII Inhibition in Rheumatoid Arthritis 2009 ·Annals of the New York Academy of Sciences ·Johanna Westra,Elisabeth Brouwer,(unknown),Berber Doornbos‐van der Meer,Marcel D. Posthumus,M. A. van Leeuwen,Pieter C. Limburg,Yutaka Ueda,Cees G. M. Kallenberg	14
12	Rituximab treatment in primary Sjogren's syndrome: A double-blind placebo controlled trial 2008 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Jiska Meijer,Arjan Vissink,Petra M. Meiners,Fred K. L. Spijkervet,Cees G. M. Kallenberg,Hendrika Bootsma	6
13	Antibody and cell-mediated responses to influenza vaccination in patients with systemic lupus erythematosus and, healthy controls 2008 ·Data Archiving and Networked Services (DANS) ·Albert Holvast,Sander van Assen,Aalzen de Haan,Anke Huckriede,Jan Wilschut,(unknown),Johanna Westra,Cees G. M. Kallenberg,A.M. Palache,(unknown)	0
14	Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded Ab_Esel liposomes 2007 ·American Journal of Physiology-Renal Physiology ·Sigrídur A. Ásgeirsdóttir,Peter J. Zwiers,Henriëtte W. M. Morselt,(unknown),Hester I. Bakker,Peter Heeringa,Jan Willem Kok,Cees G. M. Kallenberg,Grietje Molema,Jan A. A. M. Kamps	84
15	Use of mycophenolic acid in non-transplant renal diseases 2007 ·Nephrology Dialysis Transplantation ·Patricia M. Stassen,Cees G. M. Kallenberg,Coen A. Stegeman	13
16	Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis 2006 ·Current Opinion in Rheumatology ·Cees G. M. Kallenberg	44
17	Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis 2001 ·Current Opinion in Nephrology & Hypertension ·Jan Willem Cohen Tervaert,Coen A. Stegeman,Cees G. M. Kallenberg	22
18	Antimyeloperoxidase-associated Lung Disease: An Experimental Model 1999 ·American Journal of Respiratory and Critical Care Medicine ·Pascal Foucher,Peter Heeringa,Arjen H. Petersen,Minke G. Huitema,Elisabeth Brouwer,Jan Willem Cohen Tervaert,Jochum Prop,(unknown),J J Weening,Cees G. M. Kallenberg	44
19	Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases 1993 ·Hepatology ·A. H. L. Mulder,Gerda Horst,Elizabeth B. Haagsma,Pieter C. Limburg,Jan H. Kleibeuker,Cees G. M. Kallenberg	164
20	Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arteritis 1991 ·The American Journal of Medicine ·Jan Willem Cohen Tervaert,Pieter C. Limburg,Job D. Elema,Minke G. Huitema,Gerda Horst,T H Thé,Cees G. M. Kallenberg	104

About Cees G. M. Kallenberg

Cees G. M. Kallenberg is a scholar working on Rheumatology, Immunology and Nephrology, having authored 369 papers that have together received 18.0k indexed citations. Recurring topics across this work include Vasculitis and related conditions (184 papers), Systemic Lupus Erythematosus Research (83 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (60 papers). The work is most often cited by research in Rheumatology (6.6k citations), Immunology (6.8k citations) and Nephrology (2.0k citations). Cees G. M. Kallenberg has collaborated with scholars based in Netherlands, United States and Pakistan. Frequent co-authors include Coen A. Stegeman, Jan Willem Cohen Tervaert, Pieter C. Limburg, Marc Bijl, Peter Heeringa, Wayel H. Abdulahad, P. C. Limburg, Gerda Horst, Minke G. Huitema and Elisabeth Brouwer. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact